drugset / Trial / NCT02881554

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

NCT02881554

Terminated 41 enrolled University of Washington
NaSingle-groupOpen-labelDiagnostic

Summary

This pilot trial studies how well single photon emission computed tomography (SPECT)/computed tomography (CT) with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer that has or has not spread to other place in the body who are undergoing radiation therapy or surgery. Diagnostic procedures, such as sulfur colloid SPECT/CT scans, may measure normal liver tissue before, during and after treatment and help doctors plan better treatment for liver cancer patients.

Timeline

Start
2016-12-21
Primary completion
2024-07-31
Completion
2025-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Technetium Tc-99m Sulfur Colloid Diagnostic / imaging agent Intravenous